Cerebral venous thrombosis after COVID-19 vaccination: is the risk of thrombosis increased by intravascular application of the vaccine?
作者信息
Gürtler Lutz, Seitz Rainer, Schramm Wolfgang
机构信息
Ludwig-Maximilians University (LMU), Max von Pettenkofer Institute, Munich, Germany.
, Sofienstraße 70, 63225, Langen, Germany.
出版信息
Infection. 2021 Oct;49(5):1071-1074. doi: 10.1007/s15010-021-01658-x. Epub 2021 Jul 21.
Abstract
摘要
相似文献
1
Cerebral venous thrombosis after COVID-19 vaccination: is the risk of thrombosis increased by intravascular application of the vaccine?新冠病毒疫苗接种后的脑静脉血栓形成：通过血管内接种疫苗会增加血栓形成风险吗？
Infection. 2021 Oct;49(5):1071-1074. doi: 10.1007/s15010-021-01658-x. Epub 2021 Jul 21.
2
Cerebral venous thrombosis and thrombocytopenia post-COVID-19 vaccination.新冠病毒疫苗接种后发生的脑静脉血栓形成和血小板减少症
Thromb Res. 2021 Jun;202:182-183. doi: 10.1016/j.thromres.2021.04.001. Epub 2021 Apr 8.
3
SARS-CoV-2 vaccine-induced cerebral venous thrombosis.SARS-CoV-2 疫苗引起的脑静脉血栓形成。
Eur J Intern Med. 2021 Jul;89:19-21. doi: 10.1016/j.ejim.2021.05.026. Epub 2021 May 25.
4
Cerebral Venous Thrombosis Developing after COVID-19 Vaccination: VITT, VATT, TTS, and More.接种 COVID-19 疫苗后发生的脑静脉血栓：VITT、VATT、TTS 及更多。
Semin Thromb Hemost. 2022 Feb;48(1):8-14. doi: 10.1055/s-0041-1736168. Epub 2021 Oct 25.
5
Inflammation and Platelet Activation After COVID-19 Vaccines - Possible Mechanisms Behind Vaccine-Induced Immune Thrombocytopenia and Thrombosis.新冠病毒疫苗接种后的炎症和血小板活化 - 疫苗诱导免疫性血小板减少症和血栓形成的可能机制。
Front Immunol. 2021 Nov 23;12:779453. doi: 10.3389/fimmu.2021.779453. eCollection 2021.
6
Incidence of cerebral venous thrombosis and COVID-19 vaccination: possible causal effect or just chance?脑静脉血栓形成与新冠病毒疫苗接种的发生率：可能的因果关系还是纯属巧合？
Eur Heart J Cardiovasc Pharmacother. 2021 Jul 23;7(4):e77-e78. doi: 10.1093/ehjcvp/pvab036.
7
Cerebral venous thrombosis post BNT162b2 mRNA SARS-CoV-2 vaccination: A black swan event.BNT162b2 mRNA新冠疫苗接种后发生脑静脉血栓形成：一个黑天鹅事件。
Am J Hematol. 2021 Sep 1;96(9):E357-E361. doi: 10.1002/ajh.26272. Epub 2021 Jun 26.
8
Cerebral arterial and venous thrombosis due to COVID-19 vaccine-induced immune thrombotic thrombocytopenia.COVID-19 疫苗诱导免疫性血栓性血小板减少症导致的脑动脉和静脉血栓形成。
BMJ Case Rep. 2022 Jan 18;15(1):e245445. doi: 10.1136/bcr-2021-245445.
9
Delayed headache after COVID-19 vaccination: a red flag for vaccine induced cerebral venous thrombosis.接种 COVID-19 疫苗后延迟性头痛：疫苗引起的脑静脉血栓形成的一个危险信号。
J Headache Pain. 2021 Sep 17;22(1):108. doi: 10.1186/s10194-021-01324-5.
10
Immunohistologic Features of Cerebral Venous Thrombosis Due to Vaccine-Induced Immune Thrombotic Thrombocytopenia.疫苗诱导的免疫性血栓性血小板减少症所致脑静脉血栓的免疫组化特征。
Neurol Neuroimmunol Neuroinflamm. 2023 May 26;10(4). doi: 10.1212/NXI.0000000000200127. Print 2023 Jul.
引用本文的文献
1
Fighting Fire with Fire: Immunogenicity of Viral Vectored Vaccines against COVID-19.以毒攻毒：新冠病毒载体疫苗的免疫原性。
Viruses. 2022 Feb 12;14(2):380. doi: 10.3390/v14020380.
2
COVID-19, Vaccines, and Thrombotic Events: A Narrative Review.2019冠状病毒病、疫苗与血栓形成事件：一篇叙述性综述
J Clin Med. 2022 Feb 11;11(4):948. doi: 10.3390/jcm11040948.
3
Cell fusion as a link between the SARS-CoV-2 spike protein, COVID-19 complications, and vaccine side effects.细胞融合作为严重急性呼吸综合征冠状病毒2（SARS-CoV-2）刺突蛋白、新型冠状病毒肺炎（COVID-19）并发症和疫苗副作用之间的联系。
Oncotarget. 2021 Dec 7;12(25):2476-2488. doi: 10.18632/oncotarget.28088.
本文引用的文献
1
Oxford-AstraZeneca COVID-19 vaccine: need of a reasoned and effective vaccine campaign.牛津大学-阿斯利康新冠疫苗：需要一场合理且有效的疫苗接种运动。
Public Health. 2021 Jul;196:135-137. doi: 10.1016/j.puhe.2021.05.030. Epub 2021 Jun 2.
2
A 59-Year-Old Woman with Extensive Deep Vein Thrombosis and Pulmonary Thromboembolism 7 Days Following a First Dose of the Pfizer-BioNTech BNT162b2 mRNA COVID-19 Vaccine.一位 59 岁女性，在接种第一剂辉瑞-生物科技 BNT162b2 mRNA COVID-19 疫苗后 7 天出现广泛的深静脉血栓形成和肺血栓栓塞症。
Am J Case Rep. 2021 Jun 12;22:e932946. doi: 10.12659/AJCR.932946.
3
First report of a de novo iTTP episode associated with an mRNA-based anti-COVID-19 vaccination.首例与基于 mRNA 的抗 COVID-19 疫苗接种相关的新发免疫性血小板减少性紫癜（iTTP）发作。
J Thromb Haemost. 2021 Aug;19(8):2014-2018. doi: 10.1111/jth.15418. Epub 2021 Jul 5.
4
Thrombosis with thrombocytopenia syndrome associated with COVID-19 vaccines.与 COVID-19 疫苗相关的血栓性血小板减少综合征。
Am J Emerg Med. 2021 Nov;49:58-61. doi: 10.1016/j.ajem.2021.05.054. Epub 2021 May 25.
5
Mechanisms of Immunothrombosis in Vaccine-Induced Thrombotic Thrombocytopenia (VITT) Compared to Natural SARS-CoV-2 Infection.疫苗诱导的免疫性血栓性血小板减少症（VITT）与自然 SARS-CoV-2 感染中免疫血栓形成的机制比较。
J Autoimmun. 2021 Jul;121:102662. doi: 10.1016/j.jaut.2021.102662. Epub 2021 May 19.
6
SARS-CoV-2 vaccines: Lights and shadows.SARS-CoV-2 疫苗：光明与阴影。
Eur J Intern Med. 2021 Jun;88:1-8. doi: 10.1016/j.ejim.2021.04.019. Epub 2021 Apr 30.
7
Safety of COVID-19 vaccines administered in the EU: Should we be concerned?在欧盟接种的新冠疫苗的安全性：我们应该担心吗？
Toxicol Rep. 2021;8:871-879. doi: 10.1016/j.toxrep.2021.04.003. Epub 2021 Apr 20.
8
Successful treatment of vaccine-induced prothrombotic immune thrombocytopenia (VIPIT).成功治疗疫苗诱导的促血栓形成免疫性血小板减少症（VIPIT）。
J Thromb Haemost. 2021 Jul;19(7):1819-1822. doi: 10.1111/jth.15346. Epub 2021 Jun 11.
9
Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination.接种 ChAdOx1 nCov-19 疫苗后发生血栓性血小板减少症。
N Engl J Med. 2021 Jun 3;384(22):2092-2101. doi: 10.1056/NEJMoa2104840. Epub 2021 Apr 9.
10
Thrombosis and Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination.ChAdOx1新冠疫苗接种后的血栓形成和血小板减少症
N Engl J Med. 2021 Jun 3;384(22):2124-2130. doi: 10.1056/NEJMoa2104882. Epub 2021 Apr 9.
Zotero 插件